Clinical Trials · NCT06264609

Precision Medicine Approach for Osteoporosis - Follow Up Study

Enrolling By InvitationPhase 4Teriparatide (Investigational)
Phase
Phase 4
Recruitment status
Enrolling By Invitation
Sponsor
Paul F Netzel
Enrollment
40
Start date
Feb 2024
Locations
1 site, United States
Primary endpoint
Percent change in bone loss
View Teriparatide compound reference